MAY 27·BenzingaMed
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting - Vaccinex ( OTC:VCNX )
ROCHESTER, N.Y., May 27, 2025 ( GLOBE NEWSWIRE ) -- Vaccinex, Inc.